Today, Telos Capital Management Inc. Reduces Position in Monsanto Co. (MON)

Today, Telos Capital Management Inc. Reduces Position in Monsanto Co. (MON)

Telos Capital Management Inc. decreased its position in shares of Monsanto Co. (NYSE:MON) by 2.4% during the third quarter, Holdings Channel reports. The fund owned 2,366 shares of the company’s stock after selling 58 shares during the period. Telos Capital Management Inc.’s holdings in Monsanto were worth $242,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in MON. Mycio Wealth Partners LLC boosted its position in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the period. Moody National Bank Trust Division boosted its position in shares of Monsanto by 0.3% in the second quarter. Moody National Bank Trust Division now owns 4,883 shares of the company’s stock valued at $505,000 after buying an additional 15 shares during the period. Quadrant Capital Group LLC boosted its position in shares of Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock valued at $184,000 after buying an additional 16 shares during the period. Bradley Foster & Sargent Inc. CT boosted its position in shares of Monsanto by 0.3% in the third quarter. Bradley Foster & Sargent Inc. CT now owns 5,838 shares of the company’s stock valued at $597,000 after buying an additional 18 shares during the period. Finally, Advisor Partners LLC boosted its position in shares of Monsanto by 0.4% in the second quarter. Advisor Partners LLC now owns 6,238 shares of the company’s stock valued at $645,000 after buying an additional 23 shares during the period. 78.26% of the stock is currently owned by hedge funds and other institutional investors.

Monsanto Co. (NYSE:MON) traded up 0.14% during trading on Friday, hitting $102.56. 961,423 shares of the stock traded hands. Monsanto Co. has a 52-week low of $83.73 and a 52-week high of $114.26. The stock has a 50 day moving average price of $101.10 and a 200-day moving average price of $103.87. The stock has a market cap of $44.92 billion, a P/E ratio of 34.32 and a beta of 1.01.

Monsanto (NYSE:MON) last issued its earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.09. The company earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business’s revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the firm earned ($0.19) EPS. On average, analysts anticipate that Monsanto Co. will post $4.73 EPS for the current fiscal year.

MON has been the subject of several recent analyst reports. S&P Equity Research reaffirmed a “positive” rating on shares of Monsanto in a report on Thursday, September 15th. Piper Jaffray Cos. reaffirmed an “overweight” rating and issued a $118.00 target price on shares of Monsanto in a report on Sunday, August 21st. cut shares of Monsanto from a “buy” rating to an “underperform” rating and set a $110.00 target price for the company. in a report on Thursday, September 15th. Zacks Investment Research cut shares of Monsanto from a “hold” rating to a “strong sell” rating in a report on Friday, October 7th. Finally, Vetr raised shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $122.43 price objective for the company in a report on Tuesday, August 9th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and fifteen have issued a buy rating to the company. Monsanto currently has an average rating of “Hold” and an average price target of $114.06.

In other news, EVP Kerry J. Preete sold 2,745 shares of Monsanto stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $100.96, for a total value of $277,135.20. Following the completion of the transaction, the executive vice president now owns 50,056 shares in the company, valued at approximately $5,053,653.76. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Steven Mizell sold 310 shares of Monsanto stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $103.09, for a total value of $31,957.90. The disclosure for this sale can be found here. 0.88% of the stock is owned by insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Related posts

Leave a Comment